The estimated Net Worth of Jack W Singer is at least $10.5 millió dollars as of 26 February 2016. Jack Singer owns over 15,000 units of CTI BioPharma Corp stock worth over $9,453,527 and over the last 21 years Jack sold CTIC stock worth over $1,052,167.
Jack has made over 32 trades of the CTI BioPharma Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Jack sold 15,000 units of CTIC stock worth $9,450 on 26 February 2016.
The largest trade Jack's ever made was selling 101,380 units of CTI BioPharma Corp stock on 25 September 2009 worth over $124,697. On average, Jack trades about 9,252 units every 64 days since 2003. As of 26 February 2016 Jack still owns at least 1,039,992 units of CTI BioPharma Corp stock.
You can see the complete history of Jack Singer stock trades at the bottom of the page.
Jack's mailing address filed with the SEC is 501 ELLIOTT AVENUE WEST, SUITE 400, SEATTLE, WA, 98119.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over $80,110,449 worth of CTI BioPharma Corp stock and bought 9,566,060 units worth $25,487,533 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... és Advisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of $1,223,687. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth $71,666.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: